Xenon Pharmaceuticals Inc XENE
$65.26
+3.23%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-409,195,000
- Net Margin
- —
- Return on Equity
- -32.94%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 5.08
- Price / Sales
- —
Over the trailing twelve months, Xenon Pharmaceuticals Inc generated revenue of — and net income of $-409,195,000.
Key Stats
- Last Close
- $65.26
- Market Cap
- $6.31 billion
- 52-Week Range
- $30.00 – $72.66
- Average Volume
- 1.07 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.